Skip to main content
Fig. 8 | BMC Cancer

Fig. 8

From: Trefoil factors peptide-3 is associated with residual invasive breast carcinoma following neoadjuvant chemotherapy

Fig. 8

a Cytoplasmic expression of TFF3 in residual carcinoma cells (thin arrow). b Cytoplasmic expression of BCl2in residual carcinoma cells (thin arrow). c Cytoplasmic Co-localization of TFF3 and BCl2 (thin arrow). d Cytoplasmic expression of TFF3 in residual carcinoma cells (thin arrow). e Cytoplasmic expression of p-AKT1 in residual carcinoma cells (thin arrow). f Cytoplasmic Co-localization of TFF3 and p-AKT1 (thin arrow). g Cytoplasmic expression of TFF3 in residual carcinoma cells (thin arrow). h Cytoplasmic expression of NF Kappa-B in residual carcinoma cells (thin arrow). C. Cytoplasmic Co-localization of TFF3 and NF Kappa-B (thin arrow)

Back to article page